Beckman Coulter's assay is used to measure phosphorylated tau (pTau217) levels in the blood of individuals displaying signs ...

Beckman Coulter Diagnostics, a global leader in clinical diagnostics and a Danaher company, today announced it received CE ...

The study, funded by the National Institutes of Health, found certain circular RNAs can strongly indicate if symptoms are ...

The idea is straightforward: Take a blood test now, even without symptoms, and learn if you could some day develop Alzheimer's disease. Whether you should get this test is a more complicated matter.

The FDA-cleared tests aren’t designed for healthy, symptom-free people, but many people want this information anyway.

Ambitious studies have been examining the protective effects of diet, exercise and socializing — with surprising results.

Diagnosing Alzheimer’s disease has long relied on expensive and invasive procedures, often delaying care until symptoms are well advanced. With the recent US Food and Drug Administration (FDA) ...

A molecular imaging technology developed by Prof. Shai Rahimipour of Bar-Ilan University is helping scientists uncover one of ...

“I feel like he just dropped a bomb and then left,” Sam Preston said of a doctor telling her she carries the APOE4 gene ...

When I co-invented the first PET (positron emission tomography) scan to visualize brain amyloid and tau—the physical evidence of Alzheimer’s disease—I did not foresee the distressing mental impact ...